Search
Institution: GLP-1 Drugs Anticipated to Usher in a "Paradigm Shift" in Heart Disease Management
2 week ago /
Read about 0 minute
Author：小编
The recently issued guidelines by the American College of Cardiology advocate for obese patients to utilize GLP-1 medications (like semaglutide) and contemporary weight loss drugs, such as NuSH, as a preventive measure against heart disease. These guidelines consider these drugs as a frontline treatment option. This transformation could potentially encourage insurance companies to extend broader coverage for these medications, subsequently intensifying the pressure on future insurance policies.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
